Your browser doesn't support javascript.
loading
Performance of idarucizumab as antidote of dabigatran in daily clinical practice.
van der Wall, Sake J; van Rein, Nienke; van den Bemt, Bart; Kruip, Marieke J H A; Meijer, Karina; Te Boome, Liane C J; Simmers, Tim A; Alings, A Marco W; Tieleman, Robert; Klok, Frederikus A; Huisman, Menno V; Westerweel, Peter E.
Afiliación
  • van der Wall SJ; Department of Thrombosis and Hemostasis, Leiden University Medical Center, Albinusdreef 2, RC Leiden, The Netherlands.
  • van Rein N; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands.
  • van den Bemt B; Department of Pharmacy, Sint Maartens-kliniek and Radboud University Medical Center, Nijmegen, the Netherlands.
  • Kruip MJHA; Department of Hematology, Erasmus Medical Center, Rotterdam, The Netherlands.
  • Meijer K; Department of Hematology, University Medical Center of Groningen, University of Groningen, Groningen, The Netherlands.
  • Te Boome LCJ; Department of Hematology, Haaglanden Medical Center, The Hague, The Netherlands.
  • Simmers TA; Department of Cardiology, Catharina Hospital, Eindhoven, The Netherlands.
  • Alings AMW; Department of Cardiology, Amphia Hospital, Breda, The Netherlands.
  • Tieleman R; Department of Cardiology, Martini Hospital, Groningen, The Netherlands.
  • Klok FA; Department of Thrombosis and Hemostasis, Leiden University Medical Center, Albinusdreef 2, RC Leiden, The Netherlands.
  • Huisman MV; Department of Thrombosis and Hemostasis, Leiden University Medical Center, Albinusdreef 2, RC Leiden, The Netherlands.
  • Westerweel PE; Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, The Netherlands.
Europace ; 21(3): 414-420, 2019 Mar 01.
Article en En | MEDLINE | ID: mdl-30339226

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Tromboembolia / Antitrombinas / Anticuerpos Monoclonales Humanizados / Dabigatrán / Hemorragia / Hemostasis / Antídotos Tipo de estudio: Diagnostic_studies / Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Aged80 / Female / Humans / Male País/Región como asunto: Europa Idioma: En Revista: Europace Asunto de la revista: CARDIOLOGIA / FISIOLOGIA Año: 2019 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Tromboembolia / Antitrombinas / Anticuerpos Monoclonales Humanizados / Dabigatrán / Hemorragia / Hemostasis / Antídotos Tipo de estudio: Diagnostic_studies / Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Aged80 / Female / Humans / Male País/Región como asunto: Europa Idioma: En Revista: Europace Asunto de la revista: CARDIOLOGIA / FISIOLOGIA Año: 2019 Tipo del documento: Article País de afiliación: Países Bajos